These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3291313)

  • 1. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
    Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.
    Karmi SA; DePalma R; Bosch J; Dosa S; Michell A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):110-3. PubMed ID: 3291218
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 7. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal transplants maintained on low-dose cyclosporine and prednisolone.
    Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.
    Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 11. Histopathology of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):759-71. PubMed ID: 3291311
    [No Abstract]   [Full Text] [Related]  

  • 12. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
    Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against chronic progressive cyclosporine nephrotoxicity.
    Ben-Maimon CS; Burke JF; Besarab A; Jarrell BE; Francos GC; Moyer SS
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1260-2. PubMed ID: 1989206
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative pathophysiology and histopathology of cyclosporine nephrotoxicity.
    Dieperink H; Starklint H; Kemp E; Leyssac PP
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):785-91. PubMed ID: 3291315
    [No Abstract]   [Full Text] [Related]  

  • 16. Ameliorating cyclosporine nephrotoxicity with intravenous protective agents.
    Karim MS; Wood RF
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):239-43. PubMed ID: 3133854
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 19. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
    Carpenter CB; Milford EL; Kirkman RL; Strom TB; Lazarus JM; Tilney NL
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):261-5. PubMed ID: 3927537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.